BioPharma Dive 24. Feb. 2026 Novo, searching for a spark, spotlights new data for three-pronged obesity drug
BioPharma Dive 23. Jan. 2026 Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal